The TGF-β1 level was found to be influenced by hyperglycemia management or the administration of drugs that inhibit the renin-angiotensin II–aldosterone system (Rauchman and Griggs 2019; Zhao et al. 2020; Zhang et al. 2021). This evidence concerns the gene TGFB1 and Hyperglycemia.